More

FUNDING OPPORTUNITIES

The Agency of Science, Technology & Research (A*STAR) offers different funding options to support individuals, resources, ideas and major initiatives.

  • Biomedical Engineering Programme (BEP) 2020 Grant Call

    Objective:
    Administered by A*STAR’s Health & MedTech Horizontal Tech Centre, the BEP 2020 is a competitive, multidisciplinary funding initiative aimed at supporting clinically-driven MedTech innovations with promising commercialization potential. The objective is to seed early MedTech innovations, which can in turn potentially contribute to a vibrant start-up ecosystem, and encourage value capture for the local innovation landscape.

  • SINGAPORE THERAPEUTICS DEVELOPMENT REVIEW 2020 CALL FOR LETTER OF INTENT (LOI)

    Objective:
    The Singapore Therapeutics Development Review (STDR), jointly organized by the Agency for Science, Technology and Research (A*STAR), National Health Innovation Centre (NHIC) and Singapore-MIT Alliance for Research and Technology (SMART), aims to identify potential high-value drug discovery and development projects from the research community in Singapore, to render the right support and guidance to progress promising projects, and to build a sustainable pipeline of drug discovery and development projects that is aligned to Singapore’s strategic interests.

  • SINGAPORE-NEW ZEALAND BILATERAL RESEARCH PROGRAMME ON FUTURE FOODS

    Objective:
    To strengthen research and development cooperation between scientists in New Zealand and Singapore through joint scientific projects.

  • Singapore Food Story - 1st Alternative Protein Seed Challenge

    Objective:
    To address global and local limitations in dietary protein production through knowledge creation and early-stage innovation.

  • 1ST SINGAPORE-AUSTRALIA BILATERAL PROGRAMME ON "INNOVATIONS IN FOOD FOR PRECISION HEALTH" CALL FOR PROPOSALS 2019

    • Objective:
    To strengthen research and development cooperation between scientists in Australia and Singapore in food and precision health through joint scientific projects.

  • 3RD SINGAPORE-GERMANY ACADEMIC-INDUSTRY (2+2) INTERNATIONAL COLLABORATION

    • Objective:
    To promote research and development bilateral collaboration between Singapore- and German-based public and private institutes and organizations, through joint scientific projects.

  • 1ST SINGAPORE-SOUTH KOREA ACADEMIC-INDUSTRY (2+2) INTERNATIONAL COLLABORATION CALL FOR PROPOSALS 2019

    • Objective:
    To promote research and development bilateral collaboration between Singapore- and Korean-based public and private institutes and organizations through joint scientific projects.

  • ASEAN DXD INITIATIVE – FIRST CALL FOR PROPOSAL

    • Objective:
    To co-develop diagnostic products among ASEAN Member States that address unmet clinical needs in ASEAN.

  • 2ND A*STAR – AMED JOINT CALL

    • Objective:
    To strengthen research and development cooperation between scientists in Japan and Singapore in biomedical research through joint scientific projects.

  • SKIN INNOVATION GRANT

    • Objective:
    To bring together researchers and clinicians, as well as engage new industry collaborators, in high impact, interdisciplinary skin research.

  • IAF-PP

    • Objective:
    To develop industry-ready capabilities towards deepening alignment of public sector research, and to develop multidisciplinary and integrated programmes with early industry involvement.

  • IAF-ICP

    • Objective:
    To support public research performers in strategic R&D projects with industry.

  • AME IRG YIRG

    • Objective:
    To develop novel and fresh R&D ideas in line with the AME strategies and goals, and solicited through an investigator-led, ground-up mechanism across the research ecosystem.
    The AME Young Individual Research Grants(YIRG) is a sub-category of grants under the IRG and aims to groom young scientists towards conducting independent research.

  • AME PROGRAMMATIC FUNDS

    • Objective:
    To support development of new and emerging capabilities far ahead of industry's readiness to deploy them for commercial purposes and typically not prior to a 8-10 year timeframe.